Dual inhibition of the renin system by aliskiren and valsartan

被引：16
|
作者：
Birkenhaeger, Willem H.
Staessen, Jan A. [1 ]
机构：
[1] Univ Leuven, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, BE-3000 Louvain, Belgium
[2] Erasmus Univ, Rotterdam, Netherlands
来源：
LANCET | 2007年 / 370卷 / 9583期
关键词：
CONVERTING-ENZYME-INHIBITORS; RECEPTOR BLOCKERS; ANGIOTENSIN; COMBINATION; THERAPY; DISEASE;
D O I：
10.1016/S0140-6736(07)61099-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [31] Aliskiren accumulates in renin secretory granules: Evidence for the release of aliskiren-bound renin following exposure of renin-synthesizing cells to aliskiren
    Krop, M.
    Danser, A. H. J.
    JOURNAL OF HYPERTENSION, 2008, 26 : S429 - S429
  • [32] Renin inhibition by aliskiren prevents atherosclerosis progression: Comparison with irbesartan, atenolol, and amlodipine
    Mazzolai, L.
    Aubert, J. F.
    Bouzourene, K.
    Pellegrin, M.
    Hayoz, D.
    Nussberger, J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 867 - 867
  • [33] Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
    Lizakowski, Slawomir
    Tylicki, Leszek
    Rutkowski, Przemyslaw
    Renke, Marcin
    Sulikowska, Beata
    Heleniak, Zbigniew
    Donderski, Rafal
    Bednarski, Rafal
    Przybylska, Milena
    Manitius, Jacek
    Rutkowski, Boleslaw
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (05): : 221 - 227
  • [34] Renin inhibition by aliskiren prevents atherosclerosis progression - Comparison with irbesartan, atenolol, and amlodipine
    Nussberger, Juerg
    Aubert, Jean-Francois
    Bouzourene, Karima
    Pellegrin, Maxime
    Hayoz, Daniel
    Mazzolai, Lucia
    HYPERTENSION, 2008, 51 (05) : 1306 - 1311
  • [35] Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
    Hirsch, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) : 1337 - 1340
  • [36] Renin Inhibition by Aliskiren Protects Rats Against Isoproterenol Induced Myocardial Infarction
    Khan, Vasim
    Hassan, Md Quamrul
    Akhtar, Mohd
    Najmi, Abul Kalam
    DRUG RESEARCH, 2018, 68 (03) : 139 - 145
  • [37] Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos P.
    Doumas, Michael
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01): : 65 - 68
  • [38] Aliskiren and valsartan combination therapy for the management of hypertension
    Epstein, Benjamin J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 711 - 722
  • [39] Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity
    Dalla Vestra, M.
    Simioni, N.
    Masiero, A.
    MINERVA ENDOCRINOLOGICA, 2009, 34 (04) : 333 - 338
  • [40] Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption
    Azizi, M
    Ménard, J
    Bissery, A
    Guyenne, TT
    Bura-Rivière, A
    Vaidyanathan, S
    Camisasca, RP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12): : 3126 - 3133
12345